As of April 30, 2026, the Company had direct and indirect interests
in the following subsidiaries:
| Name of Entity | | Date of
Incorporation | | | Place of
Incorporation | | Shareholders | | % of
Equity
Ownership | | Principal
Activities | | YD Biopharma Limited (“YD Biopharma”) | | | March 14,
2024 | | | Cayman | | YD Bio | | | 100% | | Holding | | Yong Ding Biopharm Co., Ltd (“Yong Ding”) | | | April 23,
2013 | | | the Republic of China (“ROC” or “Taiwan”) | | YD Biopharma | | | 100% | | Sales of drugs, medical and related products in Taiwan | | YD BIO USA, INC. (“YD BIO USA”) | | | February 4,
2025 | | | Delaware (US) | | YD Biopharma | | | 100% | | Sales of drugs, medical and related products in US | | YD PharmaWings Limited (“YD PharmaWings”) | | | October 23,
2025 | | | BVI | | YD Biopharma | | | 100% | | Investment holding | | Breeze Holdings Acquisition Corp (“Breeze”) | | | March 3,
2021 | | | Delaware (US) | | YD Bio | | | 100% | | Dissolved in December 2025 |
|